ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,996.66
      1.00%
      US Tech 100
      20,877.20
      1.72%
      Dow Jones
      43,487.83
      0.78%
      Brent Oil
      79.865
      -0.44%
      Bitcoin
      106,526.68
      3.31%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. MoonLake Immunotherapeutics (MLTX) Quote

      MoonLake Immunotherapeutics

      MoonLake Immunotherapeutics (MLTX)

      NASDAQ
      43.81
      2.34
      (5.64%)
      Closed January 20 4:00PM
      Delayed by 15 minutes
      45.00
      1.19
      (2.72%)
      After Hours: 7:58PM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      45.00
      Bid
      40.00
      Ask
      44.00
      Volume
      808,040
      41.92 Day's Range 44.90
      37.55 52 Week Range 64.98
      Market Cap
      2.876B
      Previous Close
      41.47
      Open
      44.83
      Last Trade
      9
      @
      42.75
      Last Trade Time
      Financial Volume
      $ 35,454,758
      VWAP
      43.8775
      Average Volume (3m)
      261,720
      Shares Outstanding
      63,905,198
      Dividend Yield
      -
      PE Ratio
      -63.69
      Earnings Per Share (EPS)
      -0.69
      Revenue
      -
      Net Profit
      -44.08M

      About MoonLake Immunotherapeutics

      MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases. MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.

      Sector
      Blank Checks
      Industry
      Pharmaceutical Preparations
      Website
      moonlaketx.com
      Headquarters
      Grand Cayman, Cym
      Founded
      2020
      MoonLake Immunotherapeutics is listed in the Blank Checks sector of the NASDAQ with ticker MLTX. The last closing price for MoonLake Immunotherapeut... was $41.47. Over the last year, MoonLake Immunotherapeut... shares have traded in a share price range of $ 37.55 to $ 64.98.

      MoonLake Immunotherapeut... currently has 63,905,198 shares outstanding. The market capitalization of MoonLake Immunotherapeut... is $2.65 billion. MoonLake Immunotherapeut... has a price to earnings ratio (PE ratio) of -63.69.

      Ask ADVFN Intelligence (AI)

      MoonLake Immunotherapeut... (MLTX) Options Flow Summary

      MLTX Options Flow

      Overall Flow

      Bearish

      Net Premium

      -489k

      Calls / Puts

      25.00%

      Buys / Sells

      66.67%

      OTM / ITM

      25.00%

      Sweeps Ratio

      0.00%

      MLTX Latest News

      More News

      MoonLake initiates three new clinical trials and further expands the portfolio of indications for the Nanobody® sonelokimab

      New trials in three new indications have been initiated with the Nanobody® sonelokimab: Phase 3 VELA-TEEN trial in adolescent hidradenitis suppurativa (HS), Phase 2 LEDA trial in palmoplantar...

      January 08 2025
      GlobeNewswire Inc.

      Form 8-K - Current report

      December 18 2024
      Edgar (US Regulatory)

      MoonLake Immunotherapeutics starts Phase 3 IZAR program of the Nanobody® sonelokimab in patients with active psoriatic arthritis

      MoonLake Immunotherapeutics starts Phase 3 IZAR program of the Nanobody® sonelokimab in patients with active psoriatic arthritis Two trials for active psoriatic arthritis (PsA) with one focusing...

      November 13 2024
      GlobeNewswire Inc.

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      November 07 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      November 07 2024
      Edgar (US Regulatory)

      MoonLake Immunotherapeutics Reports Third Quarter 2024 Financial Results and Provides a Business Update

      MoonLake Immunotherapeutics Reports Third Quarter 2024 Financial Results and Provides a Business Update Ended the third quarter with $493.9 million in cash, cash equivalents and short-term...

      November 07 2024
      GlobeNewswire Inc.

      Form 4 - Statement of changes in beneficial ownership of securities

      October 08 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      September 11 2024
      Edgar (US Regulatory)

      MoonLake Immunotherapeutics to host a Capital Markets Update on Wednesday, September 11

      MoonLake Immunotherapeutics to host a Capital Markets Updateon Wednesday, September 11 ZUG, Switzerland, September 9, 2024 – MoonLake Immunotherapeutics AG (“MoonLake”; Nasdaq: MLTX), a...

      September 09 2024
      GlobeNewswire Inc.

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      August 07 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-3-6.254849.0641.2751669044.50551302CS
      4-6.71-12.976213498451.715641.2736650448.73745118CS
      12-1.58-3.392013739846.5858.2641.2726172050.15751917CS
      26-4.48-9.054163298349.4858.2639.3629736249.18293732CS
      52-11.7-20.634920634956.764.9837.5535185148.31151608CS
      15632.63263.78334680712.3764.984.2534501943.15208646CS
      26032.63263.78334680712.3764.984.2534501943.15208646CS

      MLTX - Frequently Asked Questions (FAQ)

      What is the current MoonLake Immunotherapeut... share price?
      The current share price of MoonLake Immunotherapeut... is $ 45.00
      How many MoonLake Immunotherapeut... shares are in issue?
      MoonLake Immunotherapeut... has 63,905,198 shares in issue
      What is the market cap of MoonLake Immunotherapeut...?
      The market capitalisation of MoonLake Immunotherapeut... is USD 2.65B
      What is the 1 year trading range for MoonLake Immunotherapeut... share price?
      MoonLake Immunotherapeut... has traded in the range of $ 37.55 to $ 64.98 during the past year
      What is the PE ratio of MoonLake Immunotherapeut...?
      The price to earnings ratio of MoonLake Immunotherapeut... is -63.69
      What is the reporting currency for MoonLake Immunotherapeut...?
      MoonLake Immunotherapeut... reports financial results in USD
      What is the latest annual profit for MoonLake Immunotherapeut...?
      The latest annual profit of MoonLake Immunotherapeut... is USD -44.08M
      What is the registered address of MoonLake Immunotherapeut...?
      The registered address for MoonLake Immunotherapeut... is P.O. BOX 309, UGLAND HOUSE, GRAND CAYMAN, 1104
      What is the MoonLake Immunotherapeut... website address?
      The website address for MoonLake Immunotherapeut... is moonlaketx.com
      Which industry sector does MoonLake Immunotherapeut... operate in?
      MoonLake Immunotherapeut... operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      BTCTBTC Digital Ltd
      $ 8.2697
      (73.73%)
      		61.45M
      BDMDBaird Medical Investment Holdings Ltd
      $ 8.80
      (62.36%)
      		18.63M
      CRKNCrown Electrokinetics Corporation
      $ 0.1235
      (54.96%)
      		764.86M
      NUKKNukkleus Inc
      $ 29.97
      (45.98%)
      		19.09M
      GSITGSI Technology
      $ 3.97
      (44.36%)
      		87.7M
      DOGZDogness International Corporation
      $ 18.23
      (-58.77%)
      		740.45k
      ORKTOrangeKloud Technology Inc
      $ 3.02
      (-24.88%)
      		21.08M
      PMAXPowell Max Ltd
      $ 0.6364
      (-23.31%)
      		4.17M
      LGCBLinkage Global Inc
      $ 0.2876
      (-22.27%)
      		890.66k
      YYAIConnexa Sports Technologies Inc
      $ 0.8299
      (-20.20%)
      		602.48k
      CRKNCrown Electrokinetics Corporation
      $ 0.1235
      (54.96%)
      		764.86M
      GCTKGlucoTrack Inc
      $ 0.0852
      (15.45%)
      		465.22M
      RIMEAlgorhythm Holdings Inc
      $ 0.0406
      (-4.02%)
      		387.23M
      TGLTreasure Global Inc
      $ 0.2459
      (14.75%)
      		267.1M
      NVDANVIDIA Corporation
      $ 137.71
      (3.10%)
      		201.4M

      MLTX Discussion

      View Posts
      Monksdream Monksdream 4 months ago
      MLTX in an up trend
      👍️0
      AKATITUS AKATITUS 1 year ago
      Sleeping
      Come on 70.00
      👍️0
      Monksdream Monksdream 2 years ago
      MLTX new 52 week high
      👍️0
      AKATITUS AKATITUS 2 years ago
      Haha. Now that's funny. 18,000 share buy at 52.00 dollars.
      👍️0
      AKATITUS AKATITUS 2 years ago
      Damm some big buys at 54.00 WoW
      👍️0
      AKATITUS AKATITUS 2 years ago
      Hope it busts soon.
      👍️0
      AKATITUS AKATITUS 2 years ago
      Looks like a good churning. Will tomorrow be the same. ??????
      👍️0
      MiamiGent MiamiGent 2 years ago
      MLTX Started the day with a bang. Falling back, presently

      MOONLAKE IMMUNOTHERAPEUTICS
      $41.80 +15.92 (+61.51%)
      As of Jun-26-202310:46:16 AM ET

      https://stockcharts.com/h-sc/ui?s=MLTX

      Wolfspeed, Genesco, PacWest Bancorp And Other Big Stocks Moving Higher On Monday
      BENZINGA
      31 mins ago
      U.S. stocks traded mixed, with the Nasdaq Composite gaining around 60 points on Monday. Here are some big stocks recording gains in today's session.

      MoonLake Immunotherapeutics (NASDAQ:MLTX) jumped 75% to $45.50 after the company's Phase 2 study for Nanobody sonelokimabint met its primary endpoint in hidradenitis suppurativa.

      (con't)
      👍️0
      AKATITUS AKATITUS 2 years ago
      So pissed I was trying to sell somethings to buy 40ts them boom 100 bucks F##########
      👍️0
      Awl416 Awl416 2 years ago
      Crazy
      👍️0
      crudeoil24 crudeoil24 3 years ago
      MoonLake Immunotherapeutics (NASDAQ: MLTX) 10% owner Bihua Chen acquired a total of 5,635,000 shares at an average price of $10.00. To acquire these shares, it cost around $28.5 million.
      👍️0

      Your Recent History

      NASDAQ
      MLTX
      MoonLake Immunotherapeut...
      ASX
      SDV
      SciDev
      EU
      CHAAA
      Hospital Center of Arles...
      BOV
      L1HX34
      L3 Harris Technologies
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads